Background Cardiovascular disease is a major cause of death in patients on maintenance hemodialysis (HD). Predictors of congestive heart failure (CHF) events in patients on HD were investigated, focusing on left ventricular (LV) function.
rom the standpoint of daily practice, being able to detect the clinical parameters that predict long-term cardiovascular prognosis would be very beneficial for patients on maintenance hemodialysis (HD). In these patients, congestive heart failure (CHF) 1 is one of the main causes of mortality, but the predictors of CHF in HD patients have not been fully evaluated. This study was designed to explore the predictors of CHF events during long-term follow-up, focusing on left ventricular (LV) function estimated by echocardiography and on the clinical characteristics.
Methods

Study Population
A total of 127 patients who were all undergoing a 4-h HD session 3 times a week (Monday, Wednesday, and Friday), were included. The baseline examination was performed on Tuesday, 1 day after the Monday HD session, and comprised M-mode and Doppler echocardiography and blood sampling. Patients with persistent atrial fibrillation, atrioventricular block, or inappropriate echocardiography recordings were excluded because Doppler indexes were included as parameters. Patients with CHF at the index examination were also excluded.
Diagnosis of Cardiac Disease
Valvular heart disease was diagnosed based on the echocardiographic findings. The diagnosis of ischemic heart disease was confirmed by 12-lead ECG, echocardiography, and coronary angiography in all cases. Arrhythmia was diagnosed by 12-lead ECG or ECG monitoring during the HD session.
Diagnosis of Hypertension (HT) and Diabetes Mellitus (DM)
HT was diagnosed when the systolic or diastolic blood pressure was more than 140 mmHg or 90 mmHg, respectively, or the patient had already been prescribed antihypertensive drugs. DM was diagnosed according to the criteria defined by the National Diabetes Data Group and World Health Organization.
Measurement of Echocardiographic Parameters
M-mode and Doppler echocardiography were performed with a Toshiba ultrasound system (model 130A equipped with 2.5 and 3.75 MHz phase-array transducers, Tokyo, Japan). All examinations were performed with the subjects in the standard left lateral position, and standard transducer positions were used. M-mode echocardiographic parameters included left atrial (LA) diameter, LV end-diastolic (LVDd) and end-systolic diameters (LVDs), LV fractional shortening (LVFS), interventricular septal thickness (IVST), and posterior wall thickness (PWT). LVFS was calculated as (LVDd -LVDs)/LVDd. LV mass (LVM) was calculated using the regression equation described by Devereux et al: 2 LVM =1.04×((IVST + PWT + LVDd) 3 -LVDd 3 )-13.6, and was divided by body surface area to determine the LVM index (LVMI), presented in g/m 2 . Transmitral flow velocity was recorded in the apical 4-chamber view by pulsed-wave Doppler echocardiography. With the guidance of real-time 2-dimensional (D) color Doppler flow imaging, the pulsed Doppler sample volume was placed at the tip of the mitral leaflets and the position was then adjusted to direct the ultrasound beam parallel to the ventricular inflow. Peak E transmitral flow velocity, peak A transmitral flow velocity, and deceleration time of the early wave were measured. The ratio of peak early to late filling velocity (E/A) was analyzed as both a continuous variable and stratified variable (normal E/A-ratio (≥0.65), low E/A-ratio (<0.65) and pseudo-normalized/restrictive E/A pattern (E/A-ratio >2.5 or E/A-ratio >1.2 with LV systolic dysfunction with LVFS <0.3)). In analyses with the E/A ratio as a continuous variable, subjects with a pseudonormalized/restrictive pattern were excluded (n=3). The LV outflow velocity pattern was recorded from the apical long-axis view with the pulsedwave Doppler sample volume positioned just below the aortic valve. Doppler-timed intervals were measured from the mitral inflow and LV outflow velocity intervals. The Tei index was calculated as ((isovolumetric contraction time + isovolumetric relaxation time)/ejection time). Five consecutive beats were measured and the values were averaged in Doppler measurements to avoid any influence of respiration on diastolic filling.
Drug Therapy
Cardiovascular drugs used during the study period are shown in Table 1 . Angiotensin-converting enzyme inhibitors or angiotensin-receptor antagonists, calcium-channel blockers, and -or -blockers were used for patients with HT. Disopyramide was used for frequent supraventricular premature contraction or paroxysmal atrial fibrillation in 10 subjects during HD. Mexiletine hydrochloride was used for ventricular premature contractions in 2 patients.
Clinical Follow-up
All patients were followed-up as outpatients for at least 5 years after the index examination (mean follow-up duration, 1,703±565 days). The CHF events were defined as hospital admission or death because of CHF, which was diagnosed based on both clinical symptoms 3 and pulmonary edema on chest X-ray.
Written informed consent was given by all patients participating in the study.
Statistical Analysis
Results are presented as the mean ± SD or frequency (%) for descriptive statistics. The predictors for a CHF event were assessed using Cox proportional hazards regression analysis. In order to clarify the most important risk factors for CHF events, significant predictors in the univariate analysis were excluded in a backward multiple Cox proportional hazard model. The final model was confirmed by time-dependent covariates analysis; the ratio of the estimated hazard across time was constant. The hazard ratio and 95% confidence interval (CI) of a continuous variable in the univariate and multivariate analyses were converted into the value of 0.1 increment in LVFS or the increase in 10 (BNP, LVMI). Although we rendered old myocardial infarction (OMI) as a potential variable to predict CHF, 4 it gave unstable results in the proportional hazard model because of the small number of patients with OMI and no occurrence of CHF in the event-free patients in our population. Thus, we introduced stratification and a separate baseline for OMI to eliminate its effect. Categorization of Hb was made with <10 g/dl as the risk side. Because LVMI and the BNP level correlated with each other, we examined 2 models that included LVMI or BNP in the multivariate model. The independent variables of the 2 models, LVMI + DM + Hb <10 g/dl and BNP + DM + Hb <10 g/dl were analyzed by backward elimination (likelihood ratio). KaplanMeier survival analysis using the log-rank test was also performed for DM and Hb <10 g/dl. All analyses were 2-tailed, and p-values <0.05 were considered statistically significant. All statistical analyses were performed on a personal computer with SPSS for Windows (Version 13.0 SPSS, Chicago, IL, USA). 
Results
After the index examination, a total of 27 cases were excluded because of persistent atrial fibrillation (n=6), atrioventricular block (n=1), inappropriate echocardiography recordings (n=14) or summation between the peaks of the early and late filling waves in the transmitral flow velocity pattern (n=6). Thus, the remaining 100 patients (Table 1) comprised the final study cohort. HT was diagnosed in 39 patients (39%) and DM in 16 patients (16%). A total of 20 patients (20%) had a cardiovascular disease: OMI, valvular heart disease, arrhythmia (frequent supraventricular or ventricular premature contractions, and paroxysmal atrial fibrillation). The clinical demographics are shown in Table 1 . Arrhythmia was counted only when medication was necessary. Baseline M-mode and Doppler echocardiographic indices, and plasma BNP and Hb concentrations are shown in Table 2 .
During the follow-up, a total of 26 patients died and the etiologies are shown in Table 3 . A total of 6 CHF events (5 deaths and 1 admission) finally resulted in deaths: 3 sudden deaths; 2 during HD and 1 at home. These patients had CHF even after the last HD and in these cases we could not completely exclude the possibility of coronary events as the final cause of death (no ECG data were available). One patient had multiple organ failure because of gastrointestinal tract perforation as the final cause of death during hospitalization for CHF. The other 2 CHF patients died of pulmonary edema (Table 4) . No echocardiographic parameters were selected. DM and Hb <10 g/dl (LVMI) were identified as independent predictive factors of CHF events in both models based on BNP or LVMI using a stepwise Cox regression model ( Table 5 ). The hazard ratio and 95% CI of DM and Hb <10 g/dl were 10.96 (1.49-80.44) and 23.00 (2.41-219.76), respectively. The ratio of the estimated hazard across time was constant (T_COV*DM; p=0.726, T_COV*Hb<10; p=0.681) by time-dependent covariate analysis. KaplanMeier analysis of cumulative rates of CHF-free survival curves are shown stratified into 2 groups on the basis of DM (Fig 1) and Hb concentration (Fig 2) . Each group with DM or Hb <10 had a significantly lower survival rate than that without DM or with Hb ≥10.
Discussion
In this report, we found that DM and a low Hb concentration were independent predictors of CHF events in patients on maintenance HD. Parameters of LV performance evaluated by echocardiography were not selected as predictors.
DM is a well-known predictor of cardiovascular events. 5 Patients with DM are 2-5-fold more likely to develop heart failure than those without DM. 6 Although DM is an important risk factor for CHF, it rarely occurs independently and in fact appears to act synergistically with other risk factors, such as HT and LV hypertrophy. 7 However, in the present study, DM was an independent risk factor and we consider this can be explained from several perspectives. Diabetic cardiomyopathy, 7, 8 which is associated with LV diastolic dysfunction, 9 and/or asymptomatic ischemia are recognized potential disorders in patients with DM. In addition, aortic stiffness is often increased and might be related to the poor cardiovascular prognosis in diabetic patients. In fact, it has been reported that patients with diabetic end-stage renal disease have a significantly higher aortic pulse wave velocity, a noninvasive measure of aortic stiffness, than nondiabetic patients and that this increase with DM contributes to the higher all-cause and cardiovascular mortality rates. 10 Aortic 10 and brachial -ankle 11 pulse wave velocity 12 are increased with increasing plasma glucose levels, 11 and in diabetic patients. 10 Chae et al reported that increased pulse pressure, which is a result of arterial stiffness and an independent predictor of the risk of CHF, was related to diabetes. 13 Thus, increased arterial stiffness might lead to decreased coronary blood flow, increased myocardial ischemia, and augmented afterload of the left ventricle, ultimately causing diastolic dysfunction 14 and CHF in diabetic patients. Because of the diabetic neuropathy in the autonomic nervous system, hypotension during HD tends to occur in diabetic patients, which leads to the possibility of a higher setting of dry weight compared with nondiabetic patients. Thus, we suspect that fluid overload might be related to CHF events in diabetic patients.
The Framingham Study revealed that LV hypertrophy is a risk factor for CHF. 3 Uremic patients are at especially high cardiovascular risk, and LV hypertrophy, which is fundamentally determined by volume and pressure load 15 and accompanies combined LV dysfunction, is the main component of this risk. 16, 17 Our study confirmed that LV hypertrophy is also a predictor of CHF events in patients on HD.
Anemia is a well-recognized precipitating cause of heart failure and over the past few years, it has emerged as a powerful independent predictor of adverse outcomes in chronic heart failure. 18, 19 Even small reductions in Hb were associated with worse outcome. 18 In patients with preserved LV ejection fraction, anemia was an independent predictor of in-hospital mortality in symptomatic patients with severe heart failure. 20 However, in this study we found that anemia was an independent predictor of CHF occurrence in patients on HD without any CHF evidence at entry point. Anemia, even when severe, rarely causes heart failure in patients with normal hearts; when this problem occurs, it is likely that the high cardiac output is superimposed on some specific car- diac abnormality such as valvular or ischemic heart disease. 21 Thus, anemia would play a more important role in the development of CHF in patients on HD compared with those without HD. High cardiac output status is recognized in anemic patients and is often associated with widened pulse pressure. 21 This mechanism may be one of the reasons for heart failure in patients on HD in whom anemia is a longstanding complication even with erythropoietin therapy.
Although we adopted the E/A ratio and Tei index 22-24 as markers of LV diastolic or combined dysfunction, expecting them to be predictors of CHF, they could not predict CHF events. Their roles as markers of cardiac dysfunction are limited in HD patients because preload status affects the value. [25] [26] [27] It has been reported that the peak E increase is associated with an increase in LA pressure or a decrease in LV compliance, resulting in an increase in the peak E/peak A and the occurrence of a pseudonormalized or restrictive pattern of transmitral flow velocity. [28] [29] [30] Evaluation of E/A in HD patients is complicated. The early diastolic mitral annulus velocity determined by Doppler tissue echocardiography (E') 31 and LV inflow propagation velocity measured from color M-mode 32, 33 are purported to be less sensitive to alterations in loading conditions than the transmitral flow velocity pattern. 31 However, several reports have revealed that, even with these techniques, the advantage over conventional parameters for the assessment of LV diastolic function is limited in patients on maintenance HD. [32] [33] [34] [35] Thus, at present, it would have been very difficult to discern the presence of LV diastolic function in our study cohort.
The association of cardiac disease at baseline would have some influence on future CHF events. In fact, 1 patient who died because of CHF at follow-up had cardiac disease at baseline. We adopted fractional shortening, E/A, Tei index, and LVMI as the confounding factors to reflect the LV dysfunction that is often associated with cardiac disease detected in HD patients.
Study Limitations
First, both the number of subjects and CHF events were small. Second, the baseline examination was performed 1 day after the last HD session, so hydration status rather than cardiac function might have affected the results, because of the interindividual variation of hydration status among patients. Third, we excluded patients with atrial fibrillation, whose cardiac function may often be worse and who may be more overhydrated than patients without it, because evaluation of E/A and the Tei index requires sinus rhythm. Fourth, in this study, 4 patients with OMI were included. Evaluation of LV systolic function by M-mode echocardiography might have been inadequate; however, 2D analysis was not available. Although OMI is a potential predictor of CHF, 4 in this study the number of patients with OMI was too small to obtain statistically stable results. Thus, a larger study with more OMI patients is warranted. Finally, we could not adjust for other confounding factors, such as Creactive protein, 36 albumin, blood pressure, and pulse pressure, 14 all of which may have influenced the prognosis of patients on HD.
Conclusions
In this study, DM and a low Hb concentration, but not LV cardiac function evaluated by M-mode and Doppler echocardiography, independently predicted CHF events in patients on HD.
